MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_01C92A36.52AFBFE0" Questo documento è una pagina Web in file unico, nota anche come archivio Web. La visualizzazione di questo messaggio indica che il browser o l'editor in uso non supporta gli archivi Web. Scaricare un browser che supporti gli archivi Web, come Microsoft Internet Explorer. ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO

La presentazione è stata ottimizzata per versioni più rece= nti di Microsoft Internet Explorer e parte del contenuto potrebbe non essere visualizzato correttamente nel browser.

Per continuare, fare clic qui.

 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/master03.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Fare clic per modificare lo stile d= el titolo
Fare clic per modificare gli stili del testo dello schema= 3;
Secondo livello
Terzo livello
Quarto livello
Quinto livello
‹data/ora›
‹piè di pagina&#= 8250;
‹N›
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/master03.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml; charset="utf-8" ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/preview.wmf Content-Transfer-Encoding: base64 Content-Type: image/x-wmf AQAJAAADhh0AAAYAFhAAAAAAFhAAACYGDwAiIFdNRkMBAAAAAAABAAEQAAAAAAIAAAAAIAAAYA0A AGAtAAABAAAAbAAAAP//////////oAAAAHgAAAAAAAAAAAAAAJ4UAAB2DwAAIEVNRgAAAQBgLQAA sAAAAAMAAAAAAAAAAAAAAAAAAACABAAAYAMAAHwBAAAdAQAAAAAAAAAAAAAAAAAAYMwFAEhZBABG AAAAKAAAABwAAABHRElDAgAAAP////8AAAAAoAAAAHgAAAAAAAAAIQAAAAgAAABiAAAADAAAAAEA AAAkAAAAJAAAAAAAgD0AAAAAAAAAAAAAgD0AAAAAAAAAAAIAAAAnAAAAGAAAAAEAAAAAAAAAAAD/ AAAAAAAlAAAADAAAAAEAAAAlAAAADAAAAAgAAIBWAAAAMAAAAP//////////oAAAAHgAAAAFAAAA +P/4//j/eAf4CXgH+An4//j/+P8lAAAADAAAAAcAAIAlAAAADAAAAAAAAIAkAAAAJAAAAAAAgEEA AAAAAAAAAAAAgEEAAAAAAAAAAAIAAAAiAAAADAAAAP////9GAAAAFAAAAAgAAABHRElDAwAAAEYA AAAoAAAAHAAAAEdESUMCAAAABwAAAGwAAAAuAAAAdwAAAAAAAABGAAAAFAAAAAgAAABHRElDAwAA AEYAAAAoAAAAHAAAAEdESUMCAAAANgAAAGwAAABqAAAAdwAAAAAAAABGAAAAFAAAAAgAAABHRElD AwAAAEYAAAAoAAAAHAAAAEdESUMCAAAAAQAAAAIAAACfAAAAHgAAAAAAAABGAAAAFAAAAAgAAABH RElDAwAAAFIAAABwAQAAAgAAAPf///8AAAAAAAAAAAAAAAC8AgAAAAAAAABAABJHAGEAcgBhAG0A bwBuAGQAAAAAAAEAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADomJIAAAAA AAAAAAC8AgAAAAAAABDSEwBHAGEAcgBhAG0AbwAJAAAAAAAAAAAAAABILNcAAwAAAMDNEwAo1BMA AQAAANcWAVv3////AAAAAAAAAAAAAAAAvAIAAAAAAAAAQAASRwBhAHIAYQBtAG8AWg0CMBAEkgBA QdcA1KaSABkAAAAAABMA4NETAPjDTzAAAAAAwM4TAPr10jA0kpIAhdcBMCjUEwAAAAAAoJKSAAAA AADUppIASKySABCtkgCoQtcAAADXALSMkgAaAAAABAAAANzOEwB/9NIwBAAAAFiMkgDUppIAAAAA AAAAAAD4zhMA3PPSMAAAAADInJIA0J6SAGR2AAgAAAAAJQAAAAwAAAACAAAAFgAAAAwAAAAYAAAA EgAAAAwAAAABAAAAGAAAAAwAAAD//wACVAAAAFQAAAALAAAACwAAABAAAAAUAAAAAQAAAMfxA0LH 8QNCCwAAABMAAAABAAAATAAAAAAAAAAAAAAAAAAAAP//////////UAAAAEwAAAAGAAAAFgAAAAwA AAAAAAAAJQAAAAwAAAANAACAKAAAAAwAAAACAAAAUgAAAHABAAACAAAA9////wAAAAAAAAAAAAAA ALwCAAAAAAAAAEAAEkcAYQByAGEAbQBvAG4AZAAAAAAAAQAAAAAAAAAAAAAAAQAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAOiYkgAAAP//AAAAAAAAAAAAAAAAvAIAAAAAAAAAQAASRwBhAHIAYQBt AG8AWg0CMBAEkgBAQdcANM4TAAAAAADIBZJ8oB4YAADPEwBRBZJ8SAcVAG0Fkny2CwryqB4YAKge GAAAAAAAoJKSAAAAAADUppIASKySABCtkgCoQtcAAADXAAAAkgAaAAAABAAAANzOEwB/9NIwBAAA AFiMkgCF1wEwKNQTAAAAAABAk5IA3PPSMCAAAADInJIA0J6SAGR2AAgAAAAAtIySABoAAAAEAAAA 3M4TAODOEwAAABUAbOcYACUAAAA4hxcAAAAKADiHFwD0zgEABAAAAETOEwAADiGrZHYACAAAAAAl AAAADAAAAAIAAAAWAAAADAAAABgAAAASAAAADAAAAAEAAAAYAAAADAAAAP//AAJUAAAAVAAAABEA AAALAAAAEgAAABQAAAABAAAAx/EDQsfxA0IRAAAAEwAAAAEAAABMAAAAAAAAAAAAAAAAAAAA//// //////9QAAAAGSAAAAIAAAAWAAAADAAAAAAAAAAlAAAADAAAAA0AAIAoAAAADAAAAAIAAABSAAAA cAEAAAIAAAD3////AAAAAAAAAAAAAAAAvAIAAAAAAAAAQAASRwBhAHIAYQBtAG8AbgBkAAAAAAAB AAAAAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA6JiSAAAAEwBRBZJ8SAcVAG0F kny2CwryqB4YAKgeGAAAAAAAoJKSAAAAAADUppIASKySABCtkgA0zhMAAAAAAMgFknygHhgAAM8T AFEFknxIBxUAbQWSfLYLCvOoHhgAqB4YAAAAAABAk5IA3PPSMCAAAADInJIA0J6SAGR2AAgAAAAA AACSABoAAAAEAAAA3M4TAODOEwAAABUAbOcYAIXXATAo1BMAAAAAAOCTkgD0zgEAIAAAAETOEwAA DiGrZHYACAAAAAC0jJIAGgAAAAQAAADczhMA4M4TAAAAFQCE6RgAJQAAADiHFwAAAAoAOIcXAPTO AQAEAAAARM4TAAAOIatkdgAIAAAAACUAAAAMAAAAAgAAABYAAAAMAAAAGAAAABIAAAAMAAAAAQAA ABgAAAAMAAAA//8AAlQAAADYAAAAEwAAAAsAAACTAAAAFAAAAAEAAADH8QNCx/EDQhMAAAATAAAA FwAAAEwAAAAAAAAAAAAAAAAAAAD//////////3wAAABFAE0AQQBUAE8ATABPAEcASQBBACAAQQAg AFMAQQBOACAATQBBAFIASQBOAE8AAAAGAAAACAAAAAYAAAAGAAAABwAAAAYAAAAHAAAABwAAAAMA AAAGAAAAAgAAAAYAAAACAAAABQAAAAYAAAAHAAAAAgAAAAgAAAAGAAAABgAAAAMAAAAHAAAABwAA ABYAAAAMAAAAAAAAACUAAAAMAAAADQAAgCgAAAAMAAAAAgAAAEYAAAAoAAAAHAAAAEdESUMCAAAA BQAAAB8AAACbAAAAcwAAAAAAAABGAAAAFAAAAAgAAABHRElDAwAAAFIAAABwAQAAAgAAAPr///8A AAAAAAAAAAAAAACQAQAAAAAAAABAABJHAGEAcgBhAG0AbwBuAGQAAAAAAAEAAAAAAAAAAAAAAAEA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADomJIAAAAAAAAAAACQAQAAAAAAABDSEwBHAGEAcgBh AG0AbwAGAAAAAAAAAAAAAADEMtcAAgAAAMDNEwAo1BMAAQAAANcWAVv6////AAAAAAAAAAAAAAAA kAEAAAAAAAAAQAASRwBhAHIAYQBtAG8AWg0CMBAEkgBUQdcA1KaSAB4AAAAAABMA4NETAPjDTzAA AAAAwM4TAPr10jA0kpIAhdcBMCjUEwAAAAAAoJKSAAAAAADUppIASKySABCtkgCoQtcAAADXALSM kgAfAAAABAAAANzOEwB/9NIwBAAAAFiMkgDUppIAAAAAAAAAAAD4zhMA3PPSMAAAAADInJIA0J6S AGR2AAgAAAAAJQAAAAwAAAACAAAAFgAAAAwAAAAYAAAAEgAAAAwAAAABAAAAGAAAAAwAAAD///8C VAAAAGwAAAAHAAAAIgAAABMAAAAoAAAAAQAAAMfxA0LH8QNCBwAAACcAAAAFAAAATAAAAAAAAAAA AAAAAAAAAP//////////WAAAAEEAbgBuAGkAIAAAAAQAAAADAAAAAwAAAAEAAAACAAAAFgAAAAwA AAAAAAAAJQAAAAwAAAANAACAKAAAAAwAAAACAAAAUgAAAHABAAACAAAA+v///wAAAAAAAAAAAAAA AJABAAAAAAAAAEAAEkcAYQByAGEAbQBvAG4AZAAAAAAAAQAAAAAAAAAAAAAAAQAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAOiYkgAAAP//AAAAAAAAAAAAAAAAkAEAAAAAAAAAQAASRwBhAHIAYQBt AG8AWg0CMBAEkgBUQdcANM4TAAAAAADIBZJ8oB4YAADPEwBRBZJ8SAcVAG0FknymCQp6qB4YAKge GAAAAAAAoJKSAAAAAADUppIASKySABCtkgCoQtcAAADXAAAAkgAfAAAABAAAANzOEwB/9NIwBAAA AFiMkgCF1wEwKNQTAAAAAABAk5IA3PPSMCAAAADInJIA0J6SAGR2AAgAAAAAtIySAB8AAAAEAAAA 3M4TAODOEwAAABUAdO4YACUAAAA4hxcAAAAKADiHFwD0zgEABAAAAETOEwAADiGrZHYACAAAAAAl AAAADAAAAAIAAAAWAAAADAAAABgAAAASAAAADAAAAAEAAAAYAAAADAAAAP///wJUAAAAVAAAABQA AAAiAAAAFAAAACgAAAABAAAAx/EDQsfxA0IUAAAAJwAAAAEAAABMAAAAAAAAAAAAAAAAAAAA//// //////9QAAAAGSAAAAEAAAAWAAAADAAAAAAAAAAlAAAADAAAAA0AAIAoAAAADAAAAAIAAABSAAAA cAEAAAIAAAD6////AAAAAAAAAAAAAAAAkAEAAAAAAAAAQAASRwBhAHIAYQBtAG8AbgBkAAAAAAAB AAAAAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA6JiSAAAAEwBRBZJ8SAcVAG0F knymCQp6qB4YAKgeGAAAAAAAoJKSAAAAAADUppIASKySABCtkgA0zhMAAAAAAMgFknygHhgAAM8T AFEFknxIBxUAbQWSfKYJCnuoHhgAqB4YAAAAAABAk5IA3PPSMCAAAADInJIA0J6SAGR2AAgAAAAA AACSAB8AAAAEAAAA3M4TAODOEwAAABUAdO4YAIXXATAo1BMAAAAAAOCTkgD0zgEAIAAAAETOEwAA DiGrZHYACAAAAAC0jJIAHwAAAAQAAADczhMA4M4TAAAAFQCk8BgAJQAAADiHFwAAAAoAOIcXAPTO AQAEAAAARM4TAAAOIatkdgAIAAAAACUAAAAMAAAAAgAAABYAAAAMAAAAGAAAABIAAAAMAAAAAQAA ABgAAAAMAAAA////AlQAAADcAAAAFQAAACIAAABgAAAAKAAAAAEAAADH8QNCx/EDQhUAAAAnAAAA GAAAAEwAAAAAAAAAAAAAAAAAAAD//////////3wAAAA3ADAAOgAgACAAIAAgACAATABVAEkARwBJ ACAAUABPAEMASABFAFQAVABJAE4ATwADAAAAAwAAAAEAAAACAAAAAgAAAAIAAAACAAAAAgAAAAMA AAAEAAAAAgAAAAUAAAACAAAAAgAAAAMAAAAFAAAABAAAAAUAAAAEAAAABAAAAAQAAAACAAAABQAA AAUAAAAWAAAADAAAAAAAAAAlAAAADAAAAA0AAIAoAAAADAAAAAIAAABSAAAAcAEAAAIAAAD6//// AAAAAAAAAAAAAAAAkAEAAAAAAAAAQAASRwBhAHIAYQBtAG8AbgBkAAAAAAABAAAAAAAAAAAAAAAB AAAAAAAAAAAAAAAAAAAAkAAAABAAAAAAAAAA6JiSAAAAEwAgmpIA1KaSAIitkgAAAAAA1KaSADgA AABUzhMA+YvmMAAAAAAvAAAAAQAAADDOEwAkzxMAIJqSAPTOEwBUq5IA4AAAAIitkgAAAAAAAQAA AAMAAAADAAAAAAAAAAEAAACUzhMA1YnmMAAAAAAAAAAALwAAAAEAAAAAAAAAAAAAAAEAAAAkzxMA 5M8TAAAAAAAxAAAAAAAAAIXXATAo1BMAAAAAAECTkgAAAAAAMAAAAAEAAADwzhMA5M8TAAAAAAAg mpIAiK2SAAAAAAAczxMA8o3mMEDPEwAAAAAAMAAAAAEAAAAkzxMA8M4TAOTPEwAAAAAAyJySAOSf kgBkdgAIAAAAACUAAAAMAAAAAgAAABYAAAAMAAAAGAAAABIAAAAMAAAAAQAAABgAAAAMAAAA//// AlQAAABQAQAAFwAAACsAAAB9AAAAMQAAAAEAAADH8QNCx/EDQhcAAAAwAAAAKwAAAEwAAAAAAAAA AAAAAAAAAAD//////////6QAAABpAGwAIAAxADAAIABmAGUAYgBiAHIAYQBpAG8AIAAxADkANwA2 ACAAdQBuACAAbgBvAHMAdAByAG8AIABjAG8AbgBjAGkAdAB0AGEAZABpAG4AbwAgAAAAAQAAAAEA AAACAAAAAwAAAAMAAAACAAAAAgAAAAIAAAADAAAAAwAAAAIAAAADAAAAAQAAAAMAAAACAAAAAwAA AAMAAAADAAAAAwAAAAIAAAADAAAAAwAAAAIAAAADAAAAAwAAAAIAAAACAAAAAgAAAAMAAAACAAAA AwAAAAMAAAADAAAAAwAAAAEAAAACAAAAAgAAAAIAAAADAAAAAQAAAAMAAAADAAAAAgAAABYAAAAM AAAAAAAAACUAAAAMAAAADQAAgCgAAAAMAAAAAgAAAFIAAABwAQAAAgAAAPr///8AAAAAAAAAAAAA AACQAQAAAAAAAABAABJHAGEAcgBhAG0AbwBuAGQAAAAAAAEAAAAAAAAAAAAAAAEAAAAAAAAAAAAA AAAAAACQAAAAEAAAAAAAAADomJIAAAAAAIitkgAAAAAAAQAAAAMAAAADAAAAAAAAAAEAAACUzhMA 1YnmMAAAAAAAAAAALwAAADTOEwAAAAAAyAWSfKAeGAAAzxMAUQWSfEgHFQBtBZJ8tgsKBqgeGACo HhgAAAAAAECTkgAAAAAAMAAAAAEAAADwzhMA5M8TAAAAAAAAAJIAiK2SAAAAAAAczxMA8o3mMEDP EwAAAAAAhdcBMCjUEwAAAAAA4JOSAOTPEwAgAAAAyJySAOSfkgBkdgAIAAAAACCakgCIrZIAAAAA ABzPEwDgzhMAAAAVAFz1GAAlAAAAOIcXAAAACgA4hxcA9M4BAAQAAABEzhMAAA4hq2R2AAgAAAAA JQAAAAwAAAACAAAAFgAAAAwAAAAYAAAAEgAAAAwAAAABAAAAGAAAAAwAAAD///8CVAAAAFQAAAB+ AAAAKwAAAH8AAAAxAAAAAQAAAMfxA0LH8QNCfgAAADAAAAABAAAATAAAAAAAAAAAAAAAAAAAAP// ////////UAAAAOgAAAACAAAAFgAAAAwAAAAAAAAAJQAAAAwAAAANAACAKAAAAAwAAAACAAAAUgAA AHABAAACAAAA+v///wAAAAAAAAAAAAAAAJABAAAAAAAAAEAAEkcAYQByAGEAbQBvAG4AZAAAAAAA AQAAAAAAAAAAAAAAAQAAABiekgAAAAAAAAAAAAAAAAAAAAAAAAAAAOiYkgAAABMAIJqSANSmkgCY rJIAAAAAANSmkgDWEgAAVM4TAPmL5jAAAAAAOAAAAAEAAAAwzhMAJM8TACCakgD0zhMAVKuSANSm kgCYrJIAmKySAODREwADAAAAAwAAAAMAAAABAAAAlM4TANWJ5jABAAAAAAAAADgAAAABAAAAAAAA AAAAAAABAAAAJM8TAOTPEwABAAAAOgAAAAAAAACF1wEwKNQTAAAAAACgkpIAAAAAADkAAAABAAAA 8M4TAOTPEwAAAAAAIJqSAJiskgAAAAAAHM8TAPKN5jBAzxMAAAAAADkAAAABAAAAJM8TAPDOEwDk zxMAAAAAAMickgC8nZIAZHYACAAAAAAlAAAADAAAAAIAAAAWAAAADAAAABgAAAASAAAADAAAAAEA AAAYAAAADAAAAP///wJUAAAAqAEAAAcAAAAyAAAAjAAAADgAAAABAAAAx/EDQsfxA0IHAAAANwAA ADoAAABMAAAAAAAAAAAAAAAAAAAA///////////AAAAAcwBvAHQAdABvAHAAbwBzAHQAbwAgAGEA IAB0AHIAYQBwAGkAYQBuAHQAbwAgAGQAaQAgAG0AaQBkAG8AbABsAG8AIABvAHMAcwBlAG8AIABk AGEAbAAgACAAZgByAGEAdABlAGwAbABvACAAcABlAHIAIAACAAAAAwAAAAIAAAACAAAAAwAAAAMA AAADAAAAAgAAAAIAAAADAAAAAgAAAAIAAAACAAAAAgAAAAIAAAACAAAAAwAAAAIAAAACAAAAAwAA AAIAAAADAAAAAgAAAAMAAAABAAAAAgAAAAUAAAABAAAAAwAAAAQAAAABAAAAAQAAAAMAAAACAAAA AwAAAAMAAAACAAAAAgAAAAMAAAACAAAAAwAAAAMAAAABAAAAAgAAAAIAAAACAAAAAgAAAAIAAAAC AAAAAgAAAAIAAAABAAAAAwAAAAIAAAADAAAAAgAAAAIAAAADAAAAFgAAAAwAAAAAAAAAJQAAAAwA AAANAACAKAAAAAwAAAACAAAAUgAAAHABAAACAAAA+v///wAAAAAAAAAAAAAAAJABAAAAAAAAAEAA EkcAYQByAGEAbQBvAG4AZAAAAAAAAQAAAAAAAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAOiYkgAAAAAAAAAAAJABAAAAAAAAENITAEcAYQByAGEAbQBvAAYAAAAAAAAAAAAAAMQy1wAC AAAAwM0TACjUEwABAAAA1xYBW/r///8AAAAAAAAAAAAAAACQAQAAAAAAAABAABJHAGEAcgBhAG0A bwBaDQIwEASSAIhB1wDUppIAKwAAAAAAEwDg0RMA+MNPMAAAAADAzhMA+vXSMDSSkgCF1wEwKNQT AAAAAACgkpIAAAAAANSmkgBIrJIAEK2SAKhC1wAAANcAtIySACwAAAAEAAAA3M4TAH/00jAEAAAA WIySANSmkgAAAAAAAAAAAPjOEwDc89IwAAAAAMickgDQnpIAZHYACAAAAAAlAAAADAAAAAIAAAAW AAAADAAAABgAAAASAAAADAAAAAEAAAAYAAAADAAAAP///wJUAAAA2AAAAAcAAAA5AAAAOwAAAD8A AAABAAAAx/EDQsfxA0IHAAAAPgAAABcAAABMAAAAAAAAAAAAAAAAAAAA//////////98AAAAYQBw AGwAYQBzAGkAYQAgAG0AaQBkAG8AbABsAGEAcgBlACAAYwAvAG8AIABsAAAAAgAAAAMAAAACAAAA AgAAAAIAAAACAAAAAgAAAAIAAAAFAAAAAQAAAAMAAAADAAAAAgAAAAEAAAACAAAAAwAAAAIAAAAC AAAAAwAAAAMAAAADAAAAAgAAAAEAAAAWAAAADAAAAAAAAAAlAAAADAAAAA0AAIAoAAAADAAAAAIA AABSAAAAcAEAAAIAAAD6////AAAAAAAAAAAAAAAAkAEAAAAAAAAAQAASRwBhAHIAYQBtAG8AbgBk AAAAAAABAAAAAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA6JiSAAAA//8AAAAA AAAAAAAAAACQAQAAAAAAAABAABJHAGEAcgBhAG0AbwBaDQIwEASSAIhB1wA0zhMAAAAAAMgFknyg HhgAAM8TAFEFknxIBxUAbQWSfLYLChOoHhgAqB4YAAAAAACgkpIAAAAAANSmkgBIrJIAEK2SAKhC 1wAAANcAAACSACwAAAAEAAAA3M4TAH/00jAEAAAAWIySAIXXATAo1BMAAAAAAECTkgDc89IwIAAA AMickgDQnpIAZHYACAAAAAC0jJIALAAAAAQAAADczhMA4M4TAAAAFQD0/RgAJQAAADiHFwAAAAoA OIcXAPTOAQAEAAAARM4TAAAOIatkdgAIAAAAACUAAAAMAAAAAgAAABYAAAAMAAAAGAAAABIAAAAM AAAAAQAAABgAAAAMAAAA////AlQAAABUAAAAPAAAADkAAAA8AAAAPwAAAAEAAADH8QNCx/EDQjwA AAA+AAAAAQAAAEwAAAAAAAAAAAAAAAAAAAD//////////1AAAAAZIAAAAQAAABYAAAAMAAAAAAAA ACUAAAAMAAAADQAAgCgAAAAMAAAAAgAAAFIAAABwAQAAAgAAAPr///8AAAAAAAAAAAAAAACQAQAA AAAAAABAABJHAGEAcgBhAG0AbwBuAGQAAAAAAAEAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAADomJIAAAATAFEFknxIBxUAbQWSfLYLChOoHhgAqB4YAAAAAACgkpIAAAAAANSm kgBIrJIAEK2SADTOEwAAAAAAyAWSfKAeGAAAzxMAUQWSfEgHFQBtBZJ8tgsKFKgeGACoHhgAAAAA AECTkgDc89IwIAAAAMickgDQnpIAZHYACAAAAAAAAJIALAAAAAQAAADczhMA4M4TAAAAFQD0/RgA hdcBMCjUEwAAAAAA4JOSAPTOAQAgAAAARM4TAAAOIatkdgAIAAAAALSMkgAsAAAABAAAANzOEwDg zhMAAAAVAJAAGQAlAAAAOIcXAAAACgA4hxcA9M4BAAQAAABEzhMAAA4hq2R2AAgAAAAAJQAAAAwA AAACAAAAFgAAAAwAAAAYAAAAEgAAAAwAAAABAAAAGAAAAAwAAAD///8CVAAAAMAAAAA9AAAAOQAA AGoAAAA/AAAAAQAAAMfxA0LH8QNCPQAAAD4AAAATAAAATAAAAAAAAAAAAAAAAAAAAP////////// dAAAAE8AcwBwAGUAZABhAGwAZQAgAGQAaQAgAEIAYQBzAGkAbABlAGEAAAAFAAAAAgAAAAQAAAAC AAAAAwAAAAMAAAABAAAAAgAAAAIAAAADAAAAAQAAAAIAAAAEAAAAAgAAAAMAAAABAAAAAgAAAAIA AAACAAAAFgAAAAwAAAAAAAAAJQAAAAwAAAANAACAKAAAAAwAAAACAAAAUgAAAMYGAAAmBg8Agg1X TUZDAQAAAAAAAQAAAAAAAAACAAAAYA0AAAAAAABgLQAAcAEAAAIAAAD6////AAAAAAAAAAAAAAAA kAEAAAAAAAAAQAASRwBhAHIAYQBtAG8AbgBkAAAAAAABAAAAAAAAAAAAAAABAAAAAAAAAAAAAAAA AAAAkAAAAA4AAAAAAAAA6JiSAAAAEwAgmpIA1KaSAGCtkgAAAAAA1KaSAIgBAABUzhMA+YvmMAAA AAAnAAAAAQAAADDOEwAkzxMAIJqSAPTOEwBUq5IA4AAAAGCtkgAAAAAAAQAAAAMAAAADAAAAAAAA AAEAAACUzhMA1YnmMAAAAAAAAAAAJwAAAAEAAAAAAAAAAAAAAAEAAAAkzxMA5M8TAAAAAAAvAAAA AAAAAIXXATAo1BMAAAAAAECTkgAAAAAAKAAAAAEAAADwzhMA5M8TAAAAAAAgmpIAYK2SAAAAAAAc zxMA8o3mMEDPEwAAAAAAKAAAAAEAAAAkzxMA8M4TAOTPEwAAAAAAyJySAIifkgBkdgAIAAAAACUA AAAMAAAAAgAAABYAAAAMAAAAGAAAABIAAAAMAAAAAQAAABgAAAAMAAAA////AlQAAAAgAQAAGQAA AE8AAAB/AAAAVQAAAAEAAADH8QNCx/EDQhkAAABUAAAAIwAAAEwAAAAAAAAAAAAAAAAAAAD///// /////5QAAABpAG4AIABxAHUAZQBzAHQAaQAgAGEAbgBuAGkAIABWAEkAVABUAE8AUgBJAE8AIABG AE8AUgBDAEUATABMAEkATgBJACAAb6QBAAAAAwAAAAIAAAADAAAAAwAAAAIAAAACAAAAAgAAAAEA AAACAAAAAgAAAAMAAAAEAAAAAQAAAAIAAAAEAAAAAgAAAAQAAAAEAAAABQAAAAQAAAACAAAABQAA AAIAAAADAAAABQAAAAQAAAAEAAAABAAAAAMAAAADAAAAAgAAAAUAAAACAAAAAwAAABYAAAAMAAAA AAAAACUAAAAMAAAADQAAgCgAAAAMAAAAAgAAAFIAAABwAQAAAgAAAPr///8AAAAAAAAAAAAAAACQ AQAAAAAAAABAABJHAGEAcgBhAG0AbwBuAGQAAAAAAAEAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAA AACAAAAABQAAAAAAAADomJIAAAATACCakgDUppIAOK2SAAAAAADUppIAOAAAAFTOEwD5i+YwAAAA ADcAAAABAAAAMM4TACTPEwAgmpIA9M4TAFSrkgDUppIAOK2SAAAAAAABAAAAAwAAAAMAAAAAAAAA AQAAAJTOEwDVieYwAAAAAAAAAAA3AAAAAQAAAAAAAAAAAAAAAQAAACTPEwDkzxMAAAAAADkAAAAA AAAAhdcBMCjUEwAAAAAAoJKSAAAAAAA4AAAAAQAAAPDOEwDkzxMAAAAAACCakgA4rZIAAAAAABzP EwDyjeYwQM8TAAAAAAA4AAAAAQAAACTPEwDwzhMA5M8TAAAAAADInJIALJ+SAGR2AAgAAAAAJQAA AAwAAAACAAAAFgAAAAwAAAAYAAAAEgAAAAwAAAABAAAAGAAAAAwAAAD///8CVAAAAGgBAAAHAAAA VwAAAHMAAABdAAAAAQAAAMfxA0LH8QNCBwAAAFwAAAAvAAAATAAAAAAAAAAAAAAAAAAAAP////// ////rAAAAGYAcgBlAHEAdQBlAG4AdABhACwAIABjAG8AbQBlACAAcwBwAGUAYwBpAGEAbABpAHoA egBhAG4AZABvACwAIABpAGwAIABTAGUAcgB2AGkAegBpAG8AIABkAGkAIAAAAAIAAAACAAAAAgAA AAMAAAADAAAAAwAAAAMAAAACAAAAAgAAAAEAAAACAAAAAwAAAAMAAAAFAAAAAgAAAAIAAAACAAAA AwAAAAIAAAADAAAAAgAAAAIAAAACAAAAAQAAAAMAAAADAAAAAgAAAAMAAAADAAAABAAAAAEAAAAC AAAAAQAAAAEAAAACAAAAAwAAAAIAAAACAAAAAwAAAAEAAAAEAAAAAQAAAAMAAAACAAAAAwAAAAEA AAACAAAAFgAAAAwAAAAAAAAAJQAAAAwAAAANAACAKAAAAAwAAAACAAAAUgAAAHABAAACAAAA+v// /wAAAAAAAAAAAAAAAJABAAAAAAAAAEAAEkcAYQByAGEAbQBvAG4AZAAAAAAAAQAAAAAAAAAAAAAA AQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAOiYkgAAAAAAAAAAAJABAAAAAAAAENITAEcAYQBy AGEAbQBvAAYAAAAAAAAAAAAAAMQy1wACAAAAwM0TACjUEwABAAAA1xYBW/r///8AAAAAAAAAAAAA AACQAQAAAAAAAABAABJHAGEAcgBhAG0AbwBaDQIwEASSAJRB1wDUppIALgAAAAAAEwDg0RMA+MNP MAAAAADAzhMA+vXSMDSSkgCF1wEwKNQTAAAAAACgkpIAAAAAANSmkgBIrJIAEK2SAKhC1wAAANcA tIySAC8AAAAEAAAA3M4TAH/00jAEAAAAWIySANSmkgAAAAAAAAAAAPjOEwDc89IwAAAAAMickgDQ npIAZHYACAAAAAAlAAAADAAAAAIAAAAWAAAADAAAABgAAAASAAAADAAAAAEAAAAYAAAADAAAAP// /wJUAAAA8AAAAAcAAABeAAAARgAAAGQAAAABAAAAx/EDQsfxA0IHAAAAYwAAABsAAABMAAAAAAAA AAAAAAAAAAAA//////////+EAAAARQBtAGEAdABvAGwAbwBnAGkAYQAgAGQAZQBsACAAUABvAGwA aQBjAGwAaQBuAGkAYwBvACAAAAAEAAAABQAAAAIAAAACAAAAAwAAAAEAAAADAAAAAwAAAAIAAAAC AAAAAgAAAAMAAAACAAAAAQAAAAIAAAAEAAAAAwAAAAEAAAABAAAAAwAAAAIAAAABAAAAAwAAAAEA AAADAAAAAwAAAAIAAAAWAAAADAAAAAAAAAAlAAAADAAAAA0AAIAoAAAADAAAAAIAAABSAAAAcAEA AAIAAAD6////AAAAAAAAAAAAAAAAkAEAAAAAAAAAQAASRwBhAHIAYQBtAG8AbgBkAAAAAAABAAAA AAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA6JiSAAAA//8AAAAAAAAAAAAAAACQ AQAAAAAAAABAABJHAGEAcgBhAG0AbwBaDQIwEASSAJRB1wA0zhMAAAAAAMgFknygHhgAAM8TAFEF knxIBxUAbQWSfKYJCqyoHhgAqB4YAAAAAACgkpIAAAAAANSmkgBIrJIAEK2SAKhC1wAAANcAAACS AC8AAAAEAAAA3M4TAH/00jAEAAAAWIySAIXXATAo1BMAAAAAAECTkgDc89IwIAAAAMickgDQnpIA ZHYACAAAAAC0jJIALwAAAAQAAADczhMA4M4TAAAAFQA8CxkAJQAAADiHFwAAAAoAOIcXAPTOAQAE AAAARM4TAAAOIatkdgAIAAAAACUAAAAMAAAAAgAAABYAAAAMAAAAGAAAABIAAAAMAAAAAQAAABgA AAAMAAAA////AlQAAAB8AAAARwAAAF4AAABaAAAAZAAAAAEAAADH8QNCx/EDQkcAAABjAAAACAAA AEwAAAAAAAAAAAAAAAAAAAD//////////1wAAABTAC4ATwByAHMAbwBsAGEAAwAAAAEAAAAFAAAA AgAAAAIAAAAEAAAAAQAAAAIAAAAWAAAADAAAAAAAAAAlAAAADAAAAA0AAIAoAAAADAAAAAIAAABS AAAAcAEAAAIAAAD6////AAAAAAAAAAAAAAAAkAEAAAAAAAAAQAASRwBhAHIAYQBtAG8AbgBkAAAA AAABAAAAAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA6JiSAAAAEwBRBZJ8SAcV AG0FknymCQqsqB4YAKgeGAAAAAAAoJKSAAAAAADUppIASKySABCtkgA0zhMAAAAAAMgFknygHhgA AM8TAFEFknxIBxUAbQWSfKYJCq2oHhgAqB4YAAAAAABAk5IA3PPSMCAAAADInJIA0J6SAGR2AAgA AAAAAACSAC8AAAAEAAAA3M4TAODOEwAAABUAPAsZAIXXATAo1BMAAAAAAOCTkgD0zgEAIAAAAETO EwAADiGrZHYACAAAAAC0jJIALwAAAAQAAADczhMA4M4TAAAAFQDwDRkAJQAAADiHFwAAAAoAOIcX APTOAQAEAAAARM4TAAAOIatkdgAIAAAAACUAAAAMAAAAAgAAABYAAAAMAAAAGAAAABIAAAAMAAAA AQAAABgAAAAMAAAA////AlQAAACIAAAAXQAAAF4AAAB2AAAAZAAAAAEAAADH8QNCx/EDQl0AAABj AAAACgAAAEwAAAAAAAAAAAAAAAAAAAD//////////2AAAABkAGkAIABCAG8AbABvAGcAbgBhAAMA AAABAAAAAgAAAAQAAAADAAAAAgAAAAMAAAADAAAAAwAAAAIAAAAWAAAADAAAAAAAAAAlAAAADAAA AA0AAIAoAAAADAAAAAIAAAAOAAAAFAAAAAAAAAAQAAAAFAAAAAQAAAADAQgABQAAAAsCAAAAAAUA AAAMAngAoAADAAAAHgAHAAAA/AIAAAAA/wAAAAQAAAAtAQAACAAAAPoCBQAAAAAA////AAQAAAAt AQEADgAAACQDBQD///////94AKAAeACgAP///////wgAAAD6AgAAAAAAAAAAAAAEAAAALQECAAcA AAD8AgAA////AAAABAAAAC0BAwAEAAAAJwH//xwAAAD7Avf/AAAAAAAAvAIAAAAAAEAAEkdhcmFt b25kAAABAAAAAAABAAAAAAAAAAAAAAAAAD8/BAAAAC0BBAAEAAAALgEYAAQAAAACAQEABQAAAAkC //8AAgkAAAAyChMACwABAAAATKYGAAQAAAAuAQAAHAAAAPsCEAAHAAAAAAC8AgAAAAABAgIiU3lz dGVtAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEAAAALQEFAAQAAADwAQQAHAAAAPsC9/8AAAAA AAC8AgAAAAAAQAASR2FyYW1vbmQAAAEAAAAAAAEAAAAAAAAAAAAAAAAAPz8EAAAALQEEAAQAAAAu ARgABAAAAAIBAQAFAAAACQL//wACCQAAADIKEwARAAEAAACSpgIABAAAAC4BAAAEAAAALQEFAAQA AADwAQQAHAAAAPsC9/8AAAAAAAC8AgAAAAAAQAASR2FyYW1vbmQAAAEAAAAAAAEAAAAAAAAAAAAA AAAAPz8EAAAALQEEAAQAAAAuARgABAAAAAIBAQAFAAAACQL//wACKgAAADIKEwATABcAAABFTUFU T0xPR0lBIEEgU0FOIE1BUklOT08GAAgABgAGAAcABgAHAAcAAwAGAAIABgACAAUABgAHAAIACAAG AAYAAwAHAAcABAAAAC4BAAAEAAAALQEFAAQAAADwAQQAHAAAAPsC+v8AAAAAAACQAQAAAAAAQAAS R2FyYW1vbmQAAAEAAAAAAAEAAAAAAAAAAAAAAAAAPz8EAAAALQEEAAQAAAAuARgABAAAAAIBAQAF AAAACQL///8CDwAAADIKJwAHAAUAAABBbm5pIG8EAAMAAwABAAIABAAAAC4BAAAEAAAALQEFAAQA AADwAQQAHAAAAPsC+v8AAAAAAACQAQAAAAAAQAASR2FyYW1vbmQAAAEAAAAAAAEAAAAAAAAAAAAA AAAAPz8EAAAALQEEAAQAAAAuARgABAAAAAIBAQAFAAAACQL///8CCQAAADIKJwAUAAEAAACSpgEA BAAAAC4BAAAEAAAALQEFAAQAAADwAQQAHAAAAPsC+v8AAAAAAACQAQAAAAAAQAASR2FyYW1vbmQA AAEAAAAAAAEAAAAAAAAAAAAAAAAAPz8EAAAALQEEAAQAAAAuARgABAAAAAIBAQAFAAAACQL///8C KwAAADIKJwAVABgAAAA3MDogICAgIExVSUdJIFBPQ0hFVFRJTk8DAAMAAQACAAIAAgACAAIAAwAE AAIABQACAAIAAwAFAAQABQAEAAQABAACAAUABQAEAAAALgEAAAQAAAAtAQUABAAAAPABBAAcAAAA +wL6/wAAAAAAAJABAAAAAABAABJHYXJhbW9uZAAAAQAAAAAAAQAAAAAAAACQABAAAAA/PwQAAAAt AQQABAAAAC4BGAAEAAAAAgEBAAUAAAAJAv///wJIAAAAMgowABcAKwAAAGlsIDEwIGZlYmJyYWlv IDE5NzYgdW4gbm9zdHJvIGNvbmNpdHRhZGlubyAAAQABAAIAAwADAAIAAgACAAMAAwACAAMAAQAD AAIAAwADAAMAAwACAAMAAwACAAMAAwACAAIAAgADAAIAAwADAAMAAwABAAIAAgACAAMAAQADAAMA AgAEAAAALgEAAAQAAAAtAQUABAAAAPABBAAcAAAA+wL6/wAAAAAAAJABAAAAAABAABJHYXJhbW9u ZAAAAQAAAAAAAQAAAAAAAACQABAAAAA/PwQAAAAtAQQABAAAAC4BGAAEAAAAAgEBAAUAAAAJAv// /wIJAAAAMgowAH4AAQAAAOimAgAEAAAALgEAAAQAAAAtAQUABAAAAPABBAAcAAAA+wL6/wAAAAAA AJABAAAAAABAABJHYXJhbW9uZAAAAQAAAAAAAQA/PwAAAAAAAAAAAAA/PwQAAAAtAQQABAAAAC4B GAAEAAAAAgEBAAUAAAAJAv///wJeAAAAMgo3AAcAOgAAAHNvdHRvcG9zdG8gYSB0cmFwaWFudG8g ZGkgbWlkb2xsbyBvc3NlbyBkYWwgIGZyYXRlbGxvIHBlciACAAMAAgACAAMAAwADAAIAAgADAAIA AgACAAIAAgACAAMAAgACAAMAAgADAAIAAwABAAIABQABAAMABAABAAEAAwACAAMAAwACAAIAAwAC AAMAAwABAAIAAgACAAIAAgACAAIAAgABAAMAAgADAAIAAgADAAQAAAAuAQAABAAAAC0BBQAEAAAA 8AEEABwAAAD7Avr/AAAAAAAAkAEAAAAAAEAAEkdhcmFtb25kAAABAAAAAAABAAAAAAAAAAAAAAAA AD8/BAAAAC0BBAAEAAAALgEYAAQAAAACAQEABQAAAAkC////AioAAAAyCj4ABwAXAAAAYXBsYXNp YSBtaWRvbGxhcmUgYy9vIGxPAgADAAIAAgACAAIAAgACAAUAAQADAAMAAgABAAIAAwACAAIAAwAD AAMAAgABAAQAAAAuAQAABAAAAC0BBQAEAAAA8AEEABwAAAD7Avr/AAAAAAAAkAEAAAAAAEAAEkdh cmFtb25kAAABAAAAAAABAAAAAAAAAAAAAAAAAD8/BAAAAC0BBAAEAAAALgEYAAQAAAACAQEABQAA AAkC////AgkAAAAyCj4APAABAAAAkqYBAAQAAAAuAQAABAAAAC0BBQAEAAAA8AEEABwAAAD7Avr/ AAAAAAAAkAEAAAAAAEAAEkdhcmFtb25kAAABAAAAAAABAAAAAAAAAAAAAAAAAD8/BAAAAC0BBAAE AAAALgEYAAQAAAACAQEABQAAAAkC////AiQAAAAyCj4APQATAAAAT3NwZWRhbGUgZGkgQmFzaWxl YS8FAAIABAACAAMAAwABAAIAAgADAAEAAgAEAAIAAwABAAIAAgACAAQAAAAuAQAABAAAAC0BBQAE AAAA8AEEABwAAAD7Avr/AAAAAAAAkAEAAAAAAEAAEkdhcmFtb25kAAABAAAAAAABAAAAAAAAAJAA DgAAAD8/BAAAAC0BBAAEAAAALgEYAAQAAAACAQEABQAAAAkC////AjwAAAAyClQAGQAjAAAAaW4g cXVlc3RpIGFubmkgVklUVE9SSU8gRk9SQ0VMTElOSSD/AQADAAIAAwADAAIAAgACAAEAAgACAAMA BAABAAIABAACAAQABAAFAAQAAgAFAAIAAwAFAAQABAAEAAMAAwACAAUAAgADAAQAAAAuAQAABAAA AC0BBQAEAAAA8AEEABwAAAD7Avr/AAAAAAAAkAEAAAAAAEAAEkdhcmFtb25kAAABAAAAAAABAAAA AAAAAD8ABQAAAD8/BAAAAC0BBAAEAAAALgEYAAQAAAACAQEABQAAAAkC////Ak4AAAAyClwABwAv AAAAZnJlcXVlbnRhLCBjb21lIHNwZWNpYWxpenphbmRvLCBpbCBTZXJ2aXppbyBkaSAAAgACAAIA AwADAAMAAwACAAIAAQACAAMAAwAFAAIAAgACAAMAAgADAAIAAgACAAEAAwADAAIAAwADAAQAAQAC AAEAAQACAAMAAgACAAMAAQAEAAEAAwACAAMAAQACAAQAAAAuAQAABAAAAC0BBQAEAAAA8AEEABwA AAD7Avr/AAAAAAAAkAEAAAAAAEAAEkdhcmFtb25kAAABAAAAAAABAAAAAAAAAAAAAAAAAD8/BAAA AC0BBAAEAAAALgEYAAQAAAACAQEABQAAAAkC////AjAAAAAyCmMABwAbAAAARW1hdG9sb2dpYSBk ZWwgUG9saWNsaW5pY28gaQQABQACAAIAAwABAAMAAwACAAIAAgADAAIAAQACAAQAAwABAAEAAwAC AAEAAwABAAMAAwACAAQAAAAuAQAABAAAAC0BBQAEAAAA8AEEABwAAAD7Avr/AAAAAAAAkAEAAAAA AEAAEkdhcmFtb25kAAABAAAAAAABAAAAAAAAAAAAAAAAAD8/BAAAAC0BBAAEAAAALgEYAAQAAAAC AQEABQAAAAkC////AhMAAAAyCmMARwAIAAAAUy5PcnNvbGEDAAEABQACAAIABAABAAIABAAAAC4B AAAEAAAALQEFAAQAAADwAQQAHAAAAPsC+v8AAAAAAACQAQAAAAAAQAASR2FyYW1vbmQAAAEAAAAA AAEAAAAAAAAAAAAAAAAAPz8EAAAALQEEAAQAAAAuARgABAAAAAIBAQAFAAAACQL///8CFgAAADIK YwBdAAoAAABkaSBCb2xvZ25hAwABAAIABAADAAIAAwADAAMAAgAEAAAALgEAAAQAAAAtAQUABAAA APABBAADAAAAAAA= ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/pres.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml; charset="utf-8" ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0002.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
L’EMATOLOGIA A SAN MARINO<= /div>
Anni ’70:     LUIGI POCHETTIN= O
il 10 febbraio 1976 un nostro concittadino è = sottoposto a trapianto di midollo osseo dal  fratello per aplasia midollare c/o l’Ospedale di Basilea
 in questi anni VITTORIO FORCELLINI=        = frequenta, come specializzando, il Servizio di         = Ematologia del Policlinico S.Orsola di Bologna
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0001.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
L’EMATOLOGIA A SAN MARINO<= /div>
Anni ‘80 e ‘90: VITTORIO FORCELLINI
Inizia e implementa l’attività di Ambulato= rio e Day Hospital ematologici
• 1997 : viene costituita l’ASLEM
• 2000 : viene costituito il SMBMDR
• 2002 : PATRIZIA PAOLINI, FRANCO NOCENTINI e   = GIULIANA GIULIANELLI con un consulente   <= span style=3D'position:absolute;top:46.15%;left:0%;width:89.08%;height:30.76%'>= esterno raccolgono il testimone da VITTORIO   = = FORCELLINI
• 2006 : viene costituito il GRUPPO FUNZIONALE DI <= span style=3D'mso-spacerun:yes'>    <= span style=3D'position:absolute;top:51.21%;left:0%;width:84.22%;height:51.21%'>= PROGETTO PER L’EMATOLOGIA
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0003.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
GRUPPO FUNZIONALE DI PROGETTO PER <= span style=3D'font-family:Garamond;font-size:73%;color:yellow'>L’EMATO= LOGIA
=
ORGANIGRAMMA
Primario di Medicina
Primario di Laboratorio/Centro Trasfusionale
NOCENTINI
PAOLINI/BUGLI
Consulente esterno
<= ![endif]>
MISSIONE
1.Assistenza specialistica ematologica ai nostri concittadini
2. Formazione e aggiornamento d= el personale afferente al gruppo
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0003_image001.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhvAAcAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAEAAAC6 ABoAgAAAAP//AAKGjI+py+0Po5y0WgkC2Lz7D4biSJbmiabqahrsC8fyTNeda+f6zvcf7gsKh0QQ sIhMKmXHpfMJ/Wmi1Oqyac1qddit98vqgsdkkbiMRp/T7O+6Dbe+4/TnvI5H3vP84L4PyDUVSEj0 V4j4cpjIiLLYCDnyGEnpMVmJeYlJedHp+QkaKjq6UAAAOw== ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0003_image002.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhAgBeAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAQAB AFwAgAAAAP///wITjAN5qJewXmxGOsrg1RXbzmVBAQA7 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0003_image003.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhAgBeAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAEAAQAB AFwAgAAAAP///wITjAN5qJewXmxGOsrg1RXbzmVBAQA7 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0003_image004.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhVgACAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAEAAABR AAEAgAAAAP///wIRjAN5qJewXmxGOsrg1RVbUwAAOw== ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0003_image005.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhVgACAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAEAAABR AAEAgAAAAP///wIRjAN5qJewXmxGOsrg1RVbUwAAOw== ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0003_image006.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlheQAcAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAAB3 ABkAgAAAAP//AAJljI+py+0Po5yg2ouz3rz7D4afIZbmiaZjoLbuC1dkTNd2Nt/63ub8D1wFh0Qc q4gc+pLM27IJhT2j1NS0ihVds9zOtgvGfMPkMRlsPnPTaiy7TX3DofI5s25H4vPEif8PGCg4UQAA Ow== ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0004.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
ATTIVITA’ AMBULATORIALE <= span style=3D'font-family:Garamond;font-size:73%;color:yellow'>EMATOLOGICA giugno 2002-febbraio 2008
(100)
774
TOTALE
(23)
178
Malattie ematologiche neoplastiche
(12)
96
Gammapatie monoclonali=
(50)
388
Malattie ematologiche non neoplastiche
(7)
50
Alterazioni ematologiche mino= ri
(8)
62
Nessuna patologia ematologica=
(%)
N.
770
Pazienti
2376
Visite
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0004_image007.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlh0AG5AHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAADO AbcAgAAAAAAA/wL/jI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si 8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFho eIiYqLjI2Oj4CBkpOUlZaXmJmam5ydnp+QkaKjpKWmp6ipqqusra6voKGys7S1tre4ubq7vL2+v7 CxwsPExcbHyMnKy8zNzs/AwdLT1NXW19jZ2tvc3d7f0NHi4+Tl5ufo6err7O3u7+Dh8vP09fb3+P n6+/z9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aNlhw7evwIMqTIkSRLmjyJMqXK lSxbunwJM6bMmTRr2ryJM6fOnTx7+vwJNKjQoUSLGj2KNKnSpUybOn0KNarUqVSrWr2KNavWrVy7 ev0KNqzYsWTLmj2LNq3atWzbun0LN67cuXTr2r2LN6/evXz7+v0LOLDgwYQLGz6MOLHixYwbO34M ObLkyZQrW76MObPmzZw7ez5ZAAA7 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0004_image008.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhyAE+AHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAAAB AAEAgAAAAAECAwICRAEAOw== ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0005.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
MALATTIE EMATOLOGICHE NON = NEOPLASTICHE<= br> giugno 2002-febbraio 2008
(4)
15
Altre
(12)
48
Malattie della coagulazione
(2)
7
Piastrinosi
(4)
17
Leucocitosi
(100)
388
TOTALE
(6)
24
Eritrocitosi
(1)
4
Pancitopenie
(13)
51
Leucopenie
(15)
58
Piastrinopenie
(43)
164
Anemie
(%)
N.
=
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0005.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml; charset="utf-8" ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0005_image009.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlh0AEjAXcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAADP ASIBgAAAAAAA/wL/jI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si 8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFho eIiYqLjI2Oj4CBkpOUlZaXmJmam5ydnp+QkaKjpKWmp6ipqqusra6voKGys7S1tre4ubq7vL2+v7 CxwsPExcbHyMnKy8zNzs/AwdLT1NXW19jZ2tvc3d7f0NHi4+Tl5ufo6err7O3u7+Dh8vP09fb3+P n6+/z9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aN/xw7evwIMqTIkSRLmjyJMqXK lSxbunwJM6bMmTRr2ryJM6fOnTx7+vwJNKjQoUSLGj2KNKnSpUybOn0KNarUqVSrWr2KNavWrVy7 ev0KNqzYsWTLmj2LNq3atWzbun0LN67cuXTr2r2LN6/evXz7+v0LOLDgwYQLGz6MOLHixYwbO34M ObLkyZQrW76MObPmzZw7e/4MOrTo0aRLmz6NOrXq1axbu34NO7bs2bRr276NO7fu3bx7+/4NPLjw 4cSLGz+OPLny5cybO38OPbr06dSrW7+OPbv27dy7e/8OPrz48eTLmz+PPr369ezbu38PP778+fTr 27+PP7/+/fz7+xH/D2CAAg5IYIEGHohggnMVAAA7 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0006.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
ANEMIE
giugno 2002-febbraio 2008
(100)
164
TOTALE
(2)
3
Anemie emolitiche
(10)
16
Anemie megaloblastiche=
(12)
20
Microcitemie
(13)
21
Anemie iporigenerative=
(63)
104
Anemie sideropeniche
(%)
N.
=
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0006_image010.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlh0AG5AHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAADO AbcAgAAAAAAA/wL/jI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si 8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFho eIiYqLjI2Oj4CBkpOUlZaXmJmam5ydnp+QkaKjpKWmp6ipqqusra6voKGys7S1tre4ubq7vL2+v7 CxwsPExcbHyMnKy8zNzs/AwdLT1NXW19jZ2tvc3d7f0NHi4+Tl5ufo6err7O3u7+Dh8vP09fb3+P n6+/z9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aNlhw7evwIMqTIkSRLmjyJMqXK lSxbunwJM6bMmTRr2ryJM6fOnTx7+vwJNKjQoUSLGj2KNKnSpUybOn0KNarUqVSrWr2KNavWrVy7 ev0KNqzYsWTLmj2LNq3atWzbun0LN67cuXTr2r2LN6/evXz7+v0LOLDgwYQLGz6MOLHixYwbO34M ObLkyZQrW76MObPmzZw7ez5ZAAA7 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0010.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
PORPORE TROMBOCITOPENICHE IMMUNI (PTI)<= br> giugno 2002-febbraio 2008
(100)
58
TOTALE=
(76)
44
altre piastrinopenie
(24)
14
PTI
(%)
N.
=
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0010_image011.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhzAHGAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAADK AcQAgAAAAAAA/wL/jI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si 8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFho eIiYqLjI2Oj4CBkpOUlZaXmJmam5ydnp+QkaKjpKWmp6ipqqusra6voKGys7S1tre4ubq7vL2+v7 CxwsPExcbHyMnKy8zNzs/AwdLT1NXW19jZ2tvc3d7f0NHi4+Tl5ufo6err7O3u7+Dh8vP09fb3+P n6+/z9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aNpRw7evwIMqTIkSRLmjyJMqXK lSxbunwJM6bMmTRr2ryJM6fOnTx7+vwJNKjQoUSLGj2KNKnSpUybOn0KNarUqVSrWr2KNavWrVy7 ev0KNqzYsWTLmj2LNq3atWzbun0LN67cuXTr2r2LN6/evXz7+v0LOLDgwYQLGz6MOLHixYwbO34M ObLkyZQrW76MObPmzZw7e/4MOrTo0aRLmz6NOrXq1WAKAAA7 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0009.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
PORPORE TROMBOCITOPENICHE IMMUNI (PTI)<= br> giugno 2002-febbraio 2008
Pazienti
Sesso
Incidenza attesa/anno
EVOLUZIONE:
Stabili senza terapia         = ;            &n= bsp;     6
Risolte senza terapia        = ;            &n= bsp;         3
Risolte con splenectomia        = ;            &n= bsp;  2
Risolte con terapia medica        = ;             1
Resistenti dopo splenectomia        = ;        2
n.       14<= /span>
m/f     6/8
n.       2.2=
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0007.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
MALATTIE EMATOLOGICHE NEOPLASTICHE<= /b>
giugno 2002-febbraio 2008
(100)
178
TOTALE=
(66)
118
Sindromi linfoproliferative
(34)
60
Sindromi mieloproliferative
(%)
N.
=
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0007_image012.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlh3QG+AHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAADb AbwAgAAAAAAA/wL/jI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si 8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFho eIiYqLjI2Oj4CBkpOUlZaXmJmam5ydnp+QkaKjpKWmp6ipqqusra6voKGys7S1tre4ubq7vL2+v7 CxwsPExcbHyMnKy8zNzs/AwdLT1NXW19jZ2tvc3d7f0NHi4+Tl5ufo6err7O3u7+Dh8vP09fb3+P n6+/z9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aNpBw7evwIMqTIkSRLmjyJMqXK lSxbunwJM6bMmTRr2ryJM6fOnTx7+vwJNKjQoUSLGj2KNKnSpUybOn0KNarUqVSrWr2KNavWrVy7 ev0KNqzYsWTLmj2LNq3atWzbun0LN67cuXTr2r2LN6/evXz7+v0LOLDgwYQLGz6MOLHixYwbO34M ObLkyZQrW76MObPmzZw7e/4MOrTo0aRLmz6NOrXqGQUAADs= ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0008.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
SINDROMI MIELOPROLIFERATIVE
giugno 2002-febbraio 2008
32/28
1/0
5/0
4/3
3/6
5/5
10/3
4/11
Sesso
M/F
60
1
5
7
9
10
13
15
N
0.2
(1)
IPEREOSINOFILIE (HES)<= /div>
0.4
(8)
MIELOFIBROSI (MF)
9.0
(100)
TOTALE
0.8
(12)
LEUCEMIE CRONICHE (LMC)
1.6
(15)
POLICITEMIE (PV)
1.8
(17)
LEUCEMIE ACUTE (LANL)<= /div>
2.2
(22)
MIELODISPLASIE (MDS)
2.2
(25)
TROMBOCITEMIE (TE)
Incidenza attesa
N/anno
(%)
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0008.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml; charset="utf-8" ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0008_image013.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlh+gH/AHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAAD4 Af0AgAAAAAAA/wL/jI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si 8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFho eIiYqLjI2Oj4CBkpOUlZaXmJmam5ydnp+QkaKjpKWmp6ipqqusra6voKGys7S1tre4ubq7vL2+v7 CxwsPExcbHyMnKy8zNzs/AwdLT1NXW19jZ2tvc3d7f0NHi4+Tl5ufo6err7O3u7+Dh8vP09fb3+P n6+/z9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aN/xw7evwIMqTIkSRLmjyJMqXK lSxbunwJM6bMmTRr2ryJM6fOnTx7+vwJNKjQoUSLGj2KNKnSpUybOn0KNarUqVSrWr2KNavWrVy7 ev0KNqzYsWTLmj2LNq3atWzbun0LN67cuXTr2r2LN6/evXz7+v0LOLDgwYQLGz6MOLHixYwbO34M ObLkyZQrW76MObPmzZw7e/4MOrTo0aRLmz6NOrXq1axbu34NO7bs2bRr276NO7fu3bx7+/4NPLjw 4cSLGz+OPLny5cybO38OPbr06dSrW7+OPbv27dy7e/8OPrz48eTLmz+PPr369ezbu38PP778+fTr 27+PP7/+/fwBFgEAADs= ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0011.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
SINDROMI LINFOPROLIFERATIVE
giugno 2002-febbraio 2008
64/54
1/1
4/1
1/4
9/4
10/10
12/9
27/25
Sesso
M/F
118
2
5
5
13
20
21
52
N
0.4
(2)
LEUCEMIE CAPELLUTE (HCL)
0.2
(4)
MACROGLOBULINEMIE (MW)=
12.4
(100)
TOTALE
0.8
(4)
LEUCEMIE ACUTE (LAL)
1.0
(11)
LINFOMI di HODGIN (LH)=
2.0
(17)
LEUCEMIE CRONICHE (LLC)
2.0
(18)
MIELOMI (MM)
6.0
(44)
LINFOMI non HODGKIN (LnH)
Incidenza attesa
N/anno
(%)
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0011.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml; charset="utf-8" ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0011_image014.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhCQL/AHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAAAI Av0AgAAAAAAA/wL/jI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si 8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFho eIiYqLjI2Oj4CBkpOUlZaXmJmam5ydnp+QkaKjpKWmp6ipqqusra6voKGys7S1tre4ubq7vL2+v7 CxwsPExcbHyMnKy8zNzs/AwdLT1NXW19jZ2tvc3d7f0NHi4+Tl5ufo6err7O3u7+Dh8vP09fb3+P n6+/z9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aN/xw7evwIMqTIkSRLmjyJMqXK lSxbunwJM6bMmTRr2ryJM6fOnTx7+vwJNKjQoUSLGj2KNKnSpUybOn0KNarUqVSrWr2KNavWrVy7 ev0KNqzYsWTLmj2LNq3atWzbun0LN67cuXTr2r2LN6/evXz7+v0LOLDgwYQLGz6MOLHixYwbO34M ObLkyZQrW76MObPmzZw7e/4MOrTo0aRLmz6NOrXq1axbu34NO7bs2bRr276NO7fu3bx7+/4NPLjw 4cSLGz+OPLny5cybO38OPbr06dSrW7+OPbv27dy7e/8OPrz48eTLmz+PPr369ezbu38PP778+fTr 27+PP7/+/fz7+wv/D2CAAg5IIDsFAAA7 ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0012.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
EVOLUZIONE DELLE SINDROMI <= span style=3D'font-family:Garamond;font-size:73%;color:yellow'>MIELOPROLIFER= ATIVE
giugno 2002-febbraio 2008
    17 (28)
/
1
2
/
9
4
1
Deceduti
      n.v.
1
/
4
/
1
/
/
Vivi in RC*
    43 (72)
1
4
5
/
1
9
14
Vivi
     5  (8)
1
/
2
/
2
/
/
Casi in Italia
   57 (95)
/
5
6
9
9
13
15
Casi in SM
   60 (%)
1
5
7
9
10
13
15
Casi
TOTALE
HES
MF
LMC
PV
LANL
MDS
TE
* RC: remissione completa
------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0012.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml; charset="utf-8" ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0012_image015.gif Content-Transfer-Encoding: base64 Content-Type: image/gif R0lGODlhCwLvAHcAMSH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACH5BAEAAAAALAAAAAAB AAEAgAAAAAECAwICRAEAOw== ------=_NextPart_01C92A36.52AFBFE0 Content-Location: file:///C:/CF5618C9/EmatologiaaSanMarino-Prof.Ricci_file/slide0013.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" L’EMATOLOGIA A SAN MARINO
EVOLUZIONE DELLE SINDROMI = LINFOPROLIFER= ATIVE
giugno 2002-febbraio 2008
    27 (23)
/
1
4
1
4
6
11
Deceduti
    49 (42)
/
/
1
9
1
10
28
Vivi in RC*
    91 (77)
2
4
1
12
16
15
41
Vivi
    26 (22)
/
/
4
1
/
9
12
Casi in Italia
  111 (94)
2
5
4
13
20
15
52
Casi in SM
  118 (%)
2
5
5
13
20
21
52
Casi
TOTALE
HCL
MW
LANL
LH
LLC
MM
LnH